| scholarly article | Q13442814 |
| P2093 | author name string | Bingxin Zhao | |
| Xiaoxia Pan | |||
| Yuanding Chen | |||
| Yuling Wen | |||
| Yumei Teng | |||
| P2860 | cites work | Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion | Q27630969 |
| Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4 | Q28757810 | ||
| Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system | Q33228923 | ||
| Vaccine-acquired rotavirus in infants with severe combined immunodeficiency | Q33920990 | ||
| 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis | Q34227701 | ||
| Structure of rotavirus | Q34331508 | ||
| Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine | Q34358803 | ||
| Intussusception among infants given an oral rotavirus vaccine | Q34513591 | ||
| Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. | Q34791255 | ||
| Evolutionary history and global spread of the emerging g12 human rotaviruses | Q35784668 | ||
| Rotavirus vaccines: update on global impact and future priorities | Q35918823 | ||
| Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG) | Q36101005 | ||
| Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. | Q36871958 | ||
| Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes | Q37422406 | ||
| Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles | Q37530403 | ||
| Rotavirus disease and vaccination: impact on genotype diversity | Q37648707 | ||
| Genotype constellation and evolution of group A rotaviruses infecting humans | Q38017485 | ||
| Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease | Q38081968 | ||
| Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery | Q39588697 | ||
| Structural polymorphism of the major capsid protein of rotavirus | Q39714820 | ||
| Amino acid domains 280-297 of VP6 and 531-554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection | Q40079198 | ||
| Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine | Q40489497 | ||
| Detection and characterization of pestivirus contaminations in human live viral vaccines | Q40691590 | ||
| Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus | Q42157032 | ||
| Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine. | Q42266696 | ||
| Epitope Mapping of the Major Inner Capsid Protein of Group A Rotavirus Using Peptide Synthesis | Q43663826 | ||
| Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. | Q44106887 | ||
| Research priorities regarding rotavirus vaccine and intussusception: a meeting summary | Q44516472 | ||
| Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles | Q44600361 | ||
| Full genomic analysis of human rotavirus strain TB-Chen isolated in China. | Q46075881 | ||
| Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. | Q51692593 | ||
| Rotavirus subunit vaccines. | Q52552208 | ||
| Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia | Q56638996 | ||
| Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis | Q56995254 | ||
| Investigation of porcine circovirus contamination in human vaccines | Q61701712 | ||
| Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins | Q67915372 | ||
| The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response | Q73992558 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rotavirus VP6 | Q123050125 |
| P304 | page(s) | 96-104 | |
| P577 | publication date | 2014-04-04 | |
| P1433 | published in | Viral Immunology | Q15756644 |
| P1476 | title | A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins | |
| P478 | volume | 27 |
Search more.